Literature DB >> 30853167

Transfusion-Associated Circulatory Overload: A Clinical Perspective.

Joachim J Bosboom1, Robert B Klanderman2, Yazan Migdady3, Barbara Bolhuis4, Denise P Veelo4, Bart F Geerts4, Michael F Murphy5, Alexander P J Vlaar2.   

Abstract

For 30 years, transfusion-associated circulatory overload (TACO) has been recognized as a serious transfusion complication. Currently, TACO is the leading cause of transfusion-related morbidity and mortality worldwide which occurs in 1% to 12% of at-risk populations. Despite an incomplete understanding of the underlying pathophysiology, TACO is defined as a collection of signs and symptoms of acute pulmonary edema due to circulatory overload occurring within 6 to 12 hours of transfusion. In the past decade, large observational cohort studies resulted in better insight into the associated transfusion risk factors leading to the development of TACO. In this clinical review, we critically analyze the pathogenesis of TACO, associated risk factors, clinical presentation, diagnostic modalities, and treatment options to guide clinicians with early detection of this syndrome and intervention to improve clinical outcomes. Future research should focus on better understanding of the pathogenesis to help advance the field of volume kinetics and endothelial barrier function.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical care; Hematology; Hemovigilance; Transfusion; Volume overload

Mesh:

Substances:

Year:  2019        PMID: 30853167     DOI: 10.1016/j.tmrv.2019.01.003

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  8 in total

1.  Differential effects of speed and volume on transfusion-associated circulatory overload: A randomized study in rats.

Authors:  Robert B Klanderman; Marije Wijnberge; Joachim J Bosboom; Joris J T H Roelofs; Dirk de Korte; Robin van Bruggen; Markus W Hollmann; Margreeth B Vroom; Denise P Veelo; Nicole P Juffermans; Bart F Geerts; Alexander P J Vlaar
Journal:  Vox Sang       Date:  2021-08-15       Impact factor: 2.996

2.  Prophylactic furosemide to prevent transfusion-associated circulatory overload: a randomized controlled study in rats.

Authors:  Robert B Klanderman; Joachim J Bosboom; Denise P Veelo; Joris J T H Roelofs; Dirk de Korte; Robin van Bruggen; Liffert Vogt; Jaap D van Buul; Markus W Hollmann; Margreeth B Vroom; Nicole P Juffermans; Bart F Geerts; Alexander P J Vlaar
Journal:  Sci Rep       Date:  2022-07-15       Impact factor: 4.996

3.  Oncology Patients Who Develop Transfusion-Associated Circulatory Overload: An Observational Study.

Authors:  Marisol Maldonado; Colleen E Villamin; Leah E Murphy; Amitava Dasgupta; Roland L Bassett; Mayrin Correa Medina; Tonita S Bates; Fernando Martinez; Adriana M Knopfelmacher Couchonal; Kimberly Klein; James M Kelley
Journal:  Lab Med       Date:  2022-07-04

Review 4.  Risk factors, management and prevention of transfusion-related acute lung injury: a comprehensive update.

Authors:  Susan A Kuldanek; Marguerite Kelher; Christopher C Silliman
Journal:  Expert Rev Hematol       Date:  2019-07-16       Impact factor: 2.929

5.  Transfusion practice in the bleeding critically ill: An international online survey-The TRACE-2 survey.

Authors:  Sanne de Bruin; Dorus Eggermont; Robin van Bruggen; Dirk de Korte; Thomas W L Scheeren; Jan Bakker; Alexander P J Vlaar
Journal:  Transfusion       Date:  2021-12-31       Impact factor: 3.337

6.  Autologous red blood cell transfusion does not result in a more profound increase in pulmonary capillary wedge pressure compared to saline in critically ill patients: A randomized crossover trial.

Authors:  Joachim J Bosboom; Robert B Klanderman; Lotte E Terwindt; Esther B Bulle; Marije Wijnberge; Susanne Eberl; Antoine H Driessen; Toon A Winkelman; Bart F Geerts; Denise P Veelo; Markus W Hollmann; Alexander P J Vlaar
Journal:  Vox Sang       Date:  2022-05-13       Impact factor: 2.996

7.  In Reply - Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients.

Authors:  Michael J Joyner; Jonathon W Senefeld; Stephen A Klassen; DeLisa Fairweather; R Scott Wright; Rickey E Carter
Journal:  Mayo Clin Proc       Date:  2020-10-01       Impact factor: 11.104

8.  Colloid osmotic pressure of contemporary and novel transfusion products.

Authors:  Robert B Klanderman; Joachim J Bosboom; Herbert Korsten; Thomas Zeiler; Ruben E A Musson; Denise P Veelo; Bart F Geerts; Robin van Bruggen; Dirk de Korte; Alexander P J Vlaar
Journal:  Vox Sang       Date:  2020-05-06       Impact factor: 2.144

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.